Precision Optics Corporation, Inc. POCI PHARMA
Company Overview
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Why Investors Should Care
Revenue has grown at a 18.3% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.21.
Recent Developments
- Jun 2025 Revenue of $19.09M (-0.1% YoY); net profit $-5.78M.
- Trailing 12 Months Year-on-year growth — revenue +108.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 18.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 18.28% |
| 1 Year: | 108.00% |
Stock Price Performance
| 1 Year: | -5.70% |
| 6 Months: | +1.04% |
| 3 Months: | -21.98% |
| 1 Month: | +3.91% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Death Cross7d ago
- RSI (14)49.64 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 18.3% over 5 years.
CONS
- Trading 26.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | POCI Precision Optics Corporation, Inc. PHARMA | 4.38 | -6.84 | $47.94M | 0.00% | -40.70% | -29.62% | 18.28% | - |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,123.91 | 37.80 | $1.00T | 0.60% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 269.12 | 31.22 | $648.55B | 1.98% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 248.78 | 70.48 | $439.62B | 2.78% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 148.46 | 118.77 | $366.28B | 2.31% | - | 6.96% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 400.84 | 25.74 | $359.79B | 2.47% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 137.70 | 20.80 | $261.73B | 3.36% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 160.04 | 23.99 | $248.20B | 2.00% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA | 603.02 | 32.49 | $222.97B | 0.29% | 8.14% | 13.51% | 8.81% | 12.95% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Dec 2013 | Mar 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.39M | 2.51M | 2.80M | 2.37M | 2.76M | 2.79M | 2.46M | 2.34M | 3.90M | 4.65M | - | - | - | - | - | - | - | - | 4.19M | 6.18M | 6.68M | 7.37M | 8.71M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.77M | 5.38M | 5.73M | 7.16M | 6.65M |
| Gross Profit | 260.23K | 205.42K | 189.23K | 112.14K | 162.51K | 312.93K | 132.34K | 217.02K | 273.53K | 167.05K | 148.41K | 278.12K | 386.74K | 300.22K | 236.15K | 462.51K | 355.72K | 455.94K | 974.12K | 917.94K | 817.02K | 975.18K | 854.44K | 818.02K | 639.03K | 1.12M | 1.73M | 1.64M | 2.60M | 1.74M | 1.46M | 1.45M | 1.86M | 1.12M | - | 417.98K | 799.19K | 946.36K | 204.66K | 2.06M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.46M | 2.16M | 2.54M | 1.95M | 2.12M |
| Operating Income | -210.72K | -252.45K | -380.43K | - | - | -237.11K | - | - | -243.68K | -293.41K | -312.10K | -162.77K | -28.27K | -59.84K | -278.82K | -298.78K | -125.61K | -80.18K | -85.88K | -551.60K | -465.45K | 1.60K | -212.72K | -256.02K | -571.95K | -460.35K | -61.12K | -101.80K | 571.07K | -493.27K | -405.29K | -704.16K | -258.53K | -1.25M | - | -2.04M | -1.36M | -1.60M | -1.74M | -64.46K |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.98M | -1.30M | -1.53M | -1.67M | 11.14K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 58.48K | 44.58K | 41.77K | 38.46K | 35.12K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.10M | -1.40M | -1.64M | -1.78M | -99.58K |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - | 8.71K |
| Net Income | -210.72K | -252.45K | -380.43K | -296.44K | -321.22K | -197.88K | -381.89K | -281.31K | -222.10K | -293.41K | -312.10K | -163.35K | -28.79K | -60.33K | -279.27K | -299.29K | -125.95K | -80.48K | -86.11K | -550.83K | -466.13K | 793 | -213.45K | 552.28K | -576.80K | -507.01K | -113.90K | -158.72K | 508.67K | -398.43K | -464.42K | -758.80K | -317.06K | -1.31M | - | -2.10M | -1.40M | -1.64M | -1.78M | -108.28K |
| Diluted EPS | -0.05 | -0.06 | -0.09 | -0.05 | -0.05 | -0.03 | -0.06 | -0.04 | -0.03 | -0.04 | -0.04 | -0.02 | 0.00 | -0.01 | -0.03 | -0.03 | -0.01 | - | - | -0.04 | -0.04 | - | - | 0.04 | -0.04 | -0.09 | -0.02 | -0.03 | 0.09 | -0.07 | -0.08 | -0.13 | -0.05 | -0.21 | -0.15 | -0.30 | - | -0.21 | -0.23 | -0.01 |
| R&D Expense | 134.91K | 92.14K | 132.96K | 76.71K | 138.89K | 140.18K | 150.77K | 108.15K | 118.28K | 116.99K | 119.22K | 122.31K | 118.43K | 90.03K | 126.36K | 100.80K | 125.41K | 121.64K | 152.15K | 228.58K | 319.88K | 151.58K | 145.97K | 146.06K | 105.19K | 113.16K | 214.90K | 245.48K | 155.26K | 206.38K | 212.76K | 221.73K | 192.77K | 400.66K | 317.75K | 211.24K | - | 311.84K | 249.57K | 267.32K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.15M | 2.52M | 3.65M | 3.91M | 3.92M | 3.15M | 4.04M | 6.80M | 9.92M | 10.67M | 15.68M | 21.04M | 19.10M | 19.09M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | 10.75M | 13.31M | 13.31M | 15.69M |
| Gross Profit | 557.41K | 654.43K | 800.79K | 798.27K | 942.02K | 773.72K | 1.48M | 2.12M | 3.36M | 3.43M | 4.93M | 7.73M | 5.80M | 3.40M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | 6.28M | 8.37M | 8.52M | 8.96M |
| Operating Income | -1.28M | -1.23M | -1.16M | -1.21M | -1.06M | -1.00M | -348.62K | -612.54K | -1.42M | -905.58K | -1.35M | -638.55K | -2.72M | -5.55M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | -581.59K | 286.99K | -2.51M | -5.34M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | 155.66K | 218.93K | 225.11K | 227.02K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | -927.46K | -142.68K | -2.95M | -5.78M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | 952 | 1.94K | 1.94K | 1.94K |
| Net Income | 960.97K | -1.79M | -1.16M | -1.18M | -1.03M | -1.01M | -351.39K | -614.87K | -1.43M | -102.83K | -928.42K | -144.61K | -2.95M | -5.78M |
| Diluted EPS | 0.78 | -0.51 | -0.26 | -0.19 | -0.15 | -0.12 | -0.04 | -0.05 | - | -0.01 | -0.18 | -0.03 | -0.49 | -0.85 |
| R&D Expense | 664.70K | 630.29K | 471.11K | 492.94K | 478.27K | 464.16K | 456.38K | 505.30K | 886.13K | 624.25K | 666.48K | 992.38K | 981.78K | 1.16M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 1.25M | 2.30M | 1.84M | 2.04M | 2.12M | 1.80M | 2.51M | 7.49M | 6.35M | 6.26M | 16.70M | 19.74M | 16.91M | 19.79M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | 6.51M | 9.86M | 7.12M | 10.06M |
| Cash & Equivalents | 19.56K | 145.92K | 1.03M | 202.38K | 241.05K | 50.06K | 118.41K | 402.74K | 2.29M | 1.13M | 861.65K | 605.75K | 2.93M | 405.28K | 1.77M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | 3.02M | 2.78M | 2.87M | 3.56M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | 2.66M | 3.91M | 3.55M | 4.34M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | 7.73M | 7.69M | 6.84M | 7.53M |
| Current Liabilities | - | 727.07K | 592.89K | 1.10M | 1.37M | 1.50M | 1.22M | 1.93M | 3.61M | 3.15M | 2.51M | 4.59M | 5.26M | 4.91M | 6.15M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | 0 | 1.96M | 2.18M | 1.90M | 1.29M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | 3.00M | 3.16M | 3.43M | 2.04M |
| Total Equity | -1.19M | 519.33K | 1.71M | 740.58K | 666.89K | 587.17K | 558.38K | 564.04K | 3.38M | 2.77M | 3.43M | 8.97M | 12.05M | 10.07M | 12.26M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 5.64M | 6.07M | 6.07M | 7.71M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.59M | -1.29M | - | - | -876.30K | -667.43K | 100.66K | -1.03M | -592.49K | 46.55K | -933.37K | -81.09K | -2.68M | -3.55M |
| Investing Cash Flow | 2.47M | -6.56K | - | - | 24.11K | -33.42K | -21.64K | -40.30K | -1.60M | -122.40K | -407.80K | -52.50K | -293.88K | -233.47K |
| Financing Cash Flow | -759.79K | 2.19M | - | - | 661.20K | 769.20K | 205.31K | 2.96M | 1.04M | -197.20K | 1.09M | 2.45M | 456.32K | 5.15M |
| Capital Expenditure | -1.72K | -11.06K | -1.68K | -62.42K | -4.37K | -27.72K | -4.45K | -140.04K | -119.15K | -75.92K | -152.74K | -52.50K | -293.88K | -233.47K |
| Free Cash Flow | -1.59M | -1.30M | - | - | -880.67K | -695.15K | 96.21K | -1.17M | -711.64K | -29.37K | -1.09M | -133.59K | -2.98M | -3.78M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | -255.90K | 2.32M | -2.52M | 1.37M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 25.9% | 26.0% | 21.9% | 20.4% | 24.1% | 24.5% | 36.7% | 31.2% | 33.9% | 32.2% | 31.4% | 36.8% | 30.3% | 17.8% |
| Operating Margin % | -59.7% | -48.9% | -31.8% | -31.0% | -26.9% | -31.8% | -8.6% | -9.0% | -14.3% | -8.5% | -8.6% | -3.0% | -14.3% | -29.1% |
| Net Margin % | 44.6% | -70.9% | -31.8% | -30.1% | -26.4% | -31.9% | -8.7% | -9.0% | -14.4% | -1.0% | -5.9% | -0.7% | -15.4% | -30.3% |
| ROE % | 185.0% | -104.5% | -156.7% | -176.8% | -176.2% | -180.2% | -62.3% | -18.2% | -51.5% | -3.0% | -10.3% | -1.2% | -29.3% | -47.2% |
| ROCE % | -247.4% | -72.1% | -156.6% | -181.9% | -170.5% | -172.3% | -60.2% | -15.8% | -44.4% | -24.1% | -11.2% | -4.4% | -22.7% | -40.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Needham Investment Management, L.L.C. | 29.63% | 1.67M | $7.45M |
| 2 | MYDA Advisors LLC | 6.65% | 375.00K | $1.67M |
| 3 | Vanguard Capital Management LLC | 5.78% | 325.75K | $1.45M |
| 4 | Nantahala Capital Management, LLC | 4.97% | 280.00K | $1.25M |
| 5 | Wealthtrust Axiom, LLC | 4.62% | 260.46K | $1.16M |
| 6 | Morgan Stanley | 3.19% | 179.69K | $801.43K |
| 7 | HighTower Advisors, LLC | 2.21% | 124.34K | $554.57K |
| 8 | Geode Capital Management, LLC | 1.17% | 66.14K | $294.97K |
| 9 | Renaissance Technologies, LLC | 0.96% | 54.10K | $241.29K |
| 10 | Essex Investment Management Co LLC | 0.83% | 46.63K | $207.97K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for POCI
Precision Optics Corporation (POCI) Stock Surges Over 23% Overnight: Why Is It Moving? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNUkRMU1JCTktYRV83WWpLcTM4WldTQTJIQVd0YnRQMlZ3RVduS1ZlY3doQ05IZjlGc1V1alVMVXpVSWZjVTF3WjJ4SzFCcHlYbkpfOU43M0ItTktzTTR0NE9CQXVTSEFYWnJTcUN6bFduUTRBQWhoWUhWUjJLNzJJQXRFMElxbVBQSGUzd3…
Precision Optics (NASDAQ: POCI) awards 50K stock options to sales SVP - Stock Titan
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPUkJ2QjRsQWFJcTRIZGNuQWVmdnBZcDRtUEhlTEUweU51bGZfTFNQUjJBQUxsSGRpYzRUcjRCTFR2bFlFWEIxUEI3Tk82bkNPekktTmZRM3JydFgwVXBTdnlYXzRwNXA2ZER2RWpac09TaDF4SFBZb004X2hBTHcyTl9xd0NJbl9tY0tIZW…
Precision Optics Corporation, Inc. Common stock (NASDAQ: POCI) Stock Price, News & Analysis - kalkine.com.au
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBMVHRTMzROVng5UWRfUUVmSm1rSEluTnVRZ2xJNEpfYjIxSWVtX2ZoLUdTQnBwUW9QclljdllIYlhhclhiek14alVzTXFMMUREcUVMeFdn?oc=5" target="_blank">Precision Optics Corporation, Inc. Common stock (NA…
POCI | Precision Optics Corporation, Inc. Financials - Revenue Breakdown - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1wMDBvejFnbWtvNHUtekJsd3ctbl8yZldjQjNlZm1OSEk5dG9XRS0zRG0zczNDbmh2V2lTMWNfZVhjZGlyMFV3YlUzdk0xME05aGxYMXc2ckNhQXZhZGdra25uelJlaFp2dk5TMDFDcnl3OTl2MktN?oc=5" target="_blank">POCI | …
Precision Optics at Lytham Partners summit: growth shifts to scale - Investing.com
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNZFUzTS1SYlR5Y2lmYXFMUy1oNks2OWZtNmRrUXd1VlVXaDFrUDhINXh4NDM3S1NheFU3Qmx2eFl4MExlUEp5ZGc0enUzUERJR2EtYjlfUHRzVkw2VU1PVmZvdDFjYWtHRmpOekxmSXBjMkVVUngtSnNZYWdWYTBBZG1lZWFTeVgtR3c4VT…
Precision Optics (POCI) senior VP reports zero insider stake - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNTnZKcWFvWURGZHNTYTRyS0FMX2F1dXZqT1ZoY0JkempfOGxPQ3VFYmJZUlR6ZDh0TjM0WFFJdjlZcUxQek5zRTFHOHhHMWprTkVPRnVrWl9aRk5QNUdmYnJERks5RlpEZE1XMDlobWt5V2pDYV9RaG9wa29CM04xZi1PREdTWFRabGxVcX…
POCI — Frequently Asked Questions
What is the current share price of Precision Optics Corporation, Inc. (POCI)?
As of 2026-09-19 21:16 PDT, Precision Optics Corporation, Inc. (POCI) trades at $4.38 on NasdaqCM. Its 52-week range is $3.90 to $5.96.
What is the market capitalisation of POCI?
Precision Optics Corporation, Inc. (POCI) has a market capitalisation of $47.94M on NasdaqCM.
What is the P/E ratio of POCI?
POCI trades at a trailing price-to-earnings (P/E) ratio of -6.84. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 2.42.
What is the return on equity (ROE) of POCI?
POCI has a return on equity (ROE) of -29.62%. Its return on capital employed (ROCE) is -40.70%.
Is POCI a good stock to buy?
This page provides a data-driven analysis of Precision Optics Corporation, Inc. (POCI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.